(Q72962724)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291358%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291358%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Vasodilator therapy of severe congestive heart failure: The special importance of angiotensin-converting enzyme inhibition with captopril (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

18 September 2023

1 reference

congestive heart failure

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

18 September 2023

author name string

N. A. Awan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291358

18 September 2023

D. T. Mason

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291358

18 September 2023

language of work or name

English

0 references

publication date

1 November 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291358%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 October 2019

https://api.elsevier.com/content/article/PII:0002870382900412?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

https://api.elsevier.com/content/article/PII:0002870382900412?httpAccept=text/plain

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

18 September 2023

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291358%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291358%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

5 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291358%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

1127-1136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291358%20AND%20SRC:MED&resulttype=core&format=json

Adrenocortical and renal hormonal function in experimental cardiac failure

30 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Endocrine factors in congestive heart failure

18 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Renin relationships in congestive cardiac failure, treated and untreated

18 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

The renin-angiotensin-aldosterone system in congestive failure in conscious dogs

18 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure

18 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Angiotensin converting enzyme inhibition in patients with congestive heart failure

18 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

18 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

18 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

18 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure

18 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.

18 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Treatment of refractory heart failure with infusion of nitroprusside.

18 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance

18 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation

18 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Effects of prazosin on forearm resistance and capacitance vessels

18 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

18 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

18 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure

18 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure

18 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside

18 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure

18 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure

18 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme

18 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

The renin-angiotensin system (first of two parts).

18 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

A specific orally active inhibitor of angiotensin-converting enzyme in man.

18 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

18 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Comparison of direct effects of angiotensin and other vasoactive agents on small and large blood vessels in several vascular beds

18 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Accentuated Vascular and Endocrine Response to Sq 20881 in Hypertension

18 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

EFFECTS OF BRADYKININ ON FOREARM VENOUS TONE AND VASCULAR RESISTANCE IN MAN

18 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

GENERAL AND REGIONAL CIRCULATORY EFFECTS OF SYNTHETIC BRADYKININ IN MAN

18 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Defective cardiac parasympathetic control in patients with heart disease

18 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Alterations in the baroreceptor reflex in conscious dogs with heart failure

18 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

THE DISTRIBUTION OF ADRENERGIC NERVE FIBRES TO THE BLOOD VESSELS IN SKELETAL MUSCLE

18 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Central vasomotor stimulation by angiotensin.

18 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release

18 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Effect of angiotensin on myocardial function

18 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Direct myocardial effects of angiotensin II

18 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

The Effect of Angiotensin on Myocardial Contractility

18 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs.

18 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Renin, aldosterone and cardiac decompensation: Studies with an oral converting enzyme inhibitor in heart failure

18 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction

18 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril

18 September 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Management of refractory congestive heart failure with prazosin

18 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Prazosin and congestive heart failure: short- and long-term therapy

18 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

18 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

Immune-complex glomerulopathy in patients treated with captopril

18 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90041-2

18 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291358%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference